Bookmark
Forward
Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase® and hypothesis on the underlying mechanism.
Clémence Delafoy, Charles Dolladille, Paul Besnier, Marion Sassier, Joanna Bourgine, Véronique Lelong-Boulouard, Joachim Alexandre, Cyril Guillaume, Sophie Fedrizzi, Basile Chrétien
European journal of clinical pharmacology 2020 JulSizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Clémence Delafoy, Charles Dolladille, Paul Besnier, Marion Sassier, Joanna Bourgine, Véronique Lelong-Boulouard, Joachim Alexandre, Cyril Guillaume, Sophie Fedrizzi, Basile Chrétien. Clinically significant drug-drug interactions between tramadol and CYP3A4 inhibitors: disproportionality analysis in VigiBase® and hypothesis on the underlying mechanism. European journal of clinical pharmacology. 2020 Jul;76(7):1049-1051
Mesh Tags
Substances
PMID: 32361903
View Full Text
